Heart patients and doctors rank what matters most in clinical trials
NCT ID NCT07378137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study asks 600 people—heart disease patients and healthcare providers—to rate how serious different complications are, like heart attack or stroke, compared to death. The goal is to better understand if patients and doctors value these events differently. The results could help make future clinical trials more meaningful by reflecting real-world preferences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help design future heart disease trials that better reflect what matters most to patients and doctors.
- What could go wrong
- This is a preference study, not a treatment trial. It will not directly improve health, and results may not change how trials are run.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xijing Hospital
RECRUITINGXi'an, Shaanxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?